Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole effects on gut microbiota in older adults
NCT02844621Phase 1Completed
- Sponsor
- UT Health San Antonio
- Start
- May 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by UT Health San Antonio. Primary endpoint: Change in fecal microbiota diversity at 14 days. Started May 2016; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02844621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02844621.